The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 2 October 2007, www.theannals.com, DOI 10.1345/aph.1K197.
The Annals of Pharmacotherapy: Vol. 41, No. 11, pp. 1798-1804. DOI 10.1345/aph.1K197
© 2007 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lenzini, P. A
Right arrow Articles by Gage, B. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lenzini, P. A
Right arrow Articles by Gage, B. F

ANTICOAGULATION

Optimal Initial Dose Adjustment of Warfarin in Orthopedic Patients

Petra A Lenzini, MS

Research Statistician, Washington University in St. Louis, St. Louis, MO

Gloria R Grice, PharmD BCPS

Assistant Professor, Saint Louis College of Pharmacy, St. Louis

Paul E Milligan, PharmD

Clinical Pharmacist, Washington University in St. Louis

Susan K Gatchel, CCRC

Research Patient Assistant, Washington University in St. Louis

Elena Deych, MS

Research Statistician, Washington University in St. Louis

Charles S Eby, MD

Associate Professor of Pathology and Immunology, Washington University in St. Louis

R Stephen J Burnett, MD FRCS(C)

Orthopaedic Surgeon, Vancouver Island Health Authority, Division of Orthopaedic Surgery, Adult Reconstructive Surgery, Vancouver, British Columbia, Canada

John C Clohisy, MD

Associate Professor of Orthopaedic Surgery, Washington University in St. Louis

Robert L Barrack, MD

C & J Knight Distinguished Professor of Orthopaedic Surgery, Department of Orthopaedic Surgery, Washington University in St. Louis

Brian F Gage, MD MS

Associate Professor of Medicine, Department of Medicine, Washington University in St. Louis

Reprints: Dr. Gage, Department of Medicine, Washington University in St. Louis, Campus Box 8005, 660 South Euclid Ave., St. Louis, MO 63110, fax 314/454-5554, bgage{at}im.wustl.edu

BACKGROUND: Warfarin sodium is commonly prescribed for the prophylaxis and treatment of venous thromboembolism. Dosing algorithms have not been widely adopted because they require a fixed initial warfarin dose (eg, 5 mg) and are not tailored to other factors that may affect the international normalized ratio (INR).

OBJECTIVE: To develop an algorithm that could predict a therapeutic warfarin dose based on drug interactions, INR response after the initial warfarin doses, and other clinical factors.

METHODS: We used stepwise regression to quantify the relationship between these factors in patients beginning prophylactic warfarin therapy immediately prior to joint replacement. In the derivation cohort (n = 271), we separately modeled the therapeutic dose after 2 and 3 initial doses. We prospectively validated these 2 models in an independent cohort (n = 105).

RESULTS: About half of the therapeutic dose variability was predictable after 3 days of therapy: R2 was 53% in the derivation cohort and 42% in the validation cohort. INR response after 3 warfarin doses (INR3) inversely correlated with therapeutic dose (p < 0.001). Intraoperative blood loss transiently, but significantly, elevated the postoperative INR values. Other significant (p < 0.03) predictors were the first and second warfarin doses (+7% and +6%, respectively, per 1 mg), and statin use (-15.0%). The model derived after 2 warfarin doses explained 32% of the variability in therapeutic dose.

CONCLUSIONS: We developed and validated algorithms that estimate therapeutic warfarin doses based on clinical factors and INR response available after 2-3 days of warfarin therapy. The algorithms are implemented online at www.WarfarinDosing.org.

Key Words: anticoagulants, orthopedics, warfarin

Published Online, October 2, 2007. www.theannals.com, DOI 10.1345/aph.1K197


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
M. H. Eckman, J. Rosand, S. M. Greenberg, and B. F. Gage
Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
Ann Intern Med, January 20, 2009; 150(2): 73 - 83.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2007 by Harvey Whitney Books Company.